MedPath

A Pilot Trial of an Individualized Web-Based Condom Use Intervention

Not Applicable
Completed
Conditions
HIV
Interventions
Behavioral: Condom-HIM
Registration Number
NCT01726153
Lead Sponsor
Centre hospitalier de l'Université de Montréal (CHUM)
Brief Summary

The purpose of this study is to evaluate the efficacy of an online intervention in increasing condom use among HIV+ gay males.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
60
Inclusion Criteria
  1. are HIV-seropositive,
  2. Men who are having sex with men,
  3. engaging in unprotected anal intercourse with a partner who is serostatus negative or unknown
  4. age 18 years and older,
  5. ability to read English
  6. have access to a computer and internet.
Exclusion Criteria

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Condom-HIMCondom-HIMIndividuals assigned to this arm must follow an on-line one session tailored intervention.
Primary Outcome Measures
NameTimeMethod
Change from Baseline in participants self-efficacy in condom use at 2-weeks post-interventionbaseline and 2-weeks post intervention

The Self-Efficacy for condom use measure contains a set of items to rate participant's belief that they will be able to use condoms every time they have anal sex in a variety of situations. A four-point response scale, ranging from 'strongly agree' (0) to 'strongly disagree' (4) is used. The psychometric properties of the measure have been examined and have been shown to have good internal consistency with Cronbach's alpha coefficient of 0.96.

Secondary Outcome Measures
NameTimeMethod
Change from Baseline in participants intention to use condoms at 2-weeks post-interventionBaseline and 2-weeks post intervention

The intention to use condoms measure asks participants their intention to consistently use condoms. The psychometric properties of the measure have been examined and have shown to have good internal consistency with Cronbach's alpha coefficient of 0.89.

Trial Locations

Locations (1)

Ryerson University

🇨🇦

Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath